Actas dermo-sifiliograficas
Low-Dose Oral Minoxidil as Treatment for COVID-19-Related Telogen Effluvium: Results From a Retrospective Series of 69 Patients.
C D Villarreal-Villarreal, E Boland-Rodriguez, D Mares-Custodio, Daniel Asz-Sigall, J F Molina-de la Garza, D Saceda-Corralo, S Vano-Galvan
Published: 202510.1016/j.ad.2025.104569
Abstract
BACKGROUND AND OBJECTIVE: Coronavirus disease 2019 (COVID-19) associated telogen effluvium (CATE) has been observed in patients after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although it is self-limiting, hair loss…
Preview only. Read the full abstract at the source